共 50 条
- [44] SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis Current Diabetes Reports, 2022, 22 : 317 - 332
- [46] Plasma leucine-rich α-2-glycoprotein 1 – a novel marker of diabetic kidney disease in children and adolescents with type 1 diabetes mellitus? Pediatric Nephrology, 2023, 38 : 4043 - 4049
- [50] Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID-19: Up to 40 months' follow-up DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5368 - 5375